tiprankstipranks
Advertisement
Advertisement
Imricor Amends Form 10 as It Tightens Compliance on U.S. Securities Rules
PremiumCompany AnnouncementsImricor Amends Form 10 as It Tightens Compliance on U.S. Securities Rules
8d ago
Imricor Issues 310,000 Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Imricor Issues 310,000 Unquoted Options Under Employee Incentive Scheme
19d ago
Imricor Targets U.S. Pediatric Market With FDA Bid for NorthStar Expansion
Premium
Company Announcements
Imricor Targets U.S. Pediatric Market With FDA Bid for NorthStar Expansion
27d ago
Imricor Marks Pivotal Year as MRI-Guided Cardiac Platform Gains Regulatory and Commercial Traction
PremiumCompany AnnouncementsImricor Marks Pivotal Year as MRI-Guided Cardiac Platform Gains Regulatory and Commercial Traction
2M ago
Imricor Widens Adjusted Loss as It Ramps Up Spending Ahead of U.S. and European Growth Push
Premium
Company Announcements
Imricor Widens Adjusted Loss as It Ramps Up Spending Ahead of U.S. and European Growth Push
2M ago
Imricor Seeks FDA 510(k) Clearance for Advantage-MR MRI-Guided EP System
Premium
Company Announcements
Imricor Seeks FDA 510(k) Clearance for Advantage-MR MRI-Guided EP System
3M ago
Imricor Options Lapse, Slightly Simplifying Capital Structure
PremiumCompany AnnouncementsImricor Options Lapse, Slightly Simplifying Capital Structure
4M ago
Imricor Issues 155,000 Unquoted Options Under Employee Incentive Plan
Premium
Company Announcements
Imricor Issues 155,000 Unquoted Options Under Employee Incentive Plan
4M ago
Imricor Wins First FDA Clearance, Opening US Market for MRI-Guided EP Catheter
Premium
Company Announcements
Imricor Wins First FDA Clearance, Opening US Market for MRI-Guided EP Catheter
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100